Study ID: PM033

Study Title

Safety of New Formulation of Glatiramer Acetate

Teva Identifier

PM033

ClinicalTrials.gov Identifier

NCT00947752

Study Status

Completed

Trial Condition(s)

Relapsing Remitting Multiple Sclerosis

Interventions

Drug: Glatiramer Acetate | Drug: Experimental Glatiramer Acetate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years and older

Trial Duration

07/01/2009 - 11/01/2009

Phase

Phase 3

Study Type

Interventional